CJC is published 12 times a year.
Sign up for Table of Contents Alerts!
Please note: CJC is published in English and Chinese. Manuscripts are published online prior to printing. The citation will change as volume, issue and page numbers are finalized.
About CJCIn July 2008, Landes Bioscience and Sun Yat-sen University Cancer Center will co-publish the international, English-language version of AI ZHENG or the Chinese Journal of Cancer (CJC). CJC will publish original research, reviews, extra views, perspectives, supplements, and spotlights in all areas of cancer research. The primary criteria for publication in CJC are originality, outstanding scientific merit, and general interest. The Editorial Board is composed of members from around the world, who will strive to maintain the highest standards for excellence in order to generate a valuable resource for an international readership. Click here to read about why you should publish in CJC |
Forthcoming Articles
|
Links |
CJC will reconsider papers rejected by Science, Nature and Cell and others. |
||
| We recognize that excellent papers may have been passed over by other journals. We will reconsider papers that have been rejected by other journals such as Nature, Science, Nature Medicine, Nature Cell Biology, Cell, Cancer Cell, NEJM, and Lancet in the original format of those journals. This saves our authors time and effort. We encourage authors to enclose the reviewers' and/or editorial comments from the original journal in order to expedite the evaluation of the article. Of course, it is also possible that the article might be accepted based on its previous review. This will allow the urgent and competitive research to be published on the day of submission. Presubmission inquires may be sent to Dr. Blagosklonny, Editor for North America. | ||